Development and Validation of UV-Spectrophotometric Method for Estimation of in Marketed Formulation and Nanoformulation

被引:0
作者
Kumar, H. B. Chethan [1 ,2 ]
Kurangi, Bhaskar [1 ]
Soudagar, Moazzim [1 ]
Chimgave, Supriya [2 ]
Patil, Swapnil [1 ]
机构
[1] KLE Acad Higher Educ & Res, KLE Coll Pharm, Dept Pharmaceut, Belagavi, Karnataka, India
[2] KLE Acad Higher Educ & Res, KLE Coll Pharm, Dept Pharmacognosy, Belagavi, Karnataka, India
关键词
UV; visible spectrophotometric method; Vinpocetine; Validation; Marketed formulations; Stability study; Periwinkle; APOVINCAMINIC ACID; VINPOCETINE; METABOLITE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A quick, accurate, and cost-effective UV spectroscopy method was developed to estimate the Vinpocetine concentration in bulk, tablet dosage formulations and niosomes formulations, using a solvent ratio of (6:4) methanol: water. According to ICH guidelines, the proposed technique was validated and developed. In spite of parameters were validated by using UV/visible spectroscopy technique to analyze a spiked Vinpocetine solution. The wavelength at which the drug's maximum absorbance peak was obtained at 274 nm and the solvents used as methanol: water (6:4 w/v). The ethanol injection technique was used to prepare niosomes to analyze Vinpocetine in UV / visible spectrophotometric method. During the inter and intra-day studies, it was discovered that the developed UV technique was accurate, with % relative standard deviation ranging from 0.27 to 0.46 and 0.26 to 0.46, respectively. Vinpocetine overall recovery percentage was discovered to be between 98.42 to 99.82 %. LOQ and LOD were calculated to estimate the method's sensitivity, and they were observed to be 0.4565 mu g/ml and 0.1506 mu g/ ml, respectively. The estimation of Vinpocetine content in bulk form, marketed formulations and niosomes was achieved using the developed methodology. : A quick, accurate, and economical UV spectrophotometric method has been developed that estimates the vinpocetine concentration in bulk, tablet dosage formulations, and niosomes formulations.
引用
收藏
页码:717 / 723
页数:7
相关论文
共 33 条
  • [1] Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation
    Abou-Taleb, Heba A.
    Khallaf, Rasha A.
    Abdel-Aleem, Jelan A.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3501 - 3516
  • [2] Bhadra S, 2011, Chromatography Research International, V2011
  • [3] Bhat P., 2013, Asian J. Pharm. Res. Develop., V1, P83
  • [4] Chimagave S.S., 2023, J APPL PHARM SCI, V13, P039, DOI [DOI 10.7324/JAPS.2023.130205, 10.7324/JAPS.2023.130205]
  • [5] Chimagave Supriya S., 2020, Indian Journal of Health Sciences and Biomedical Research KLEU, V13, P120, DOI 10.4103/kleuhsj.kleuhsj_163_19
  • [6] Development and Validation of Stability Indicating UV-Spectrophotometric Method for the Estimation of Hesperidin in Bulk Drugs, Plant Extract, Ayurveda Formulation and Nanoformulation
    Chimagave, Supriya Suresh
    Jalalpure, Sunil Satyappa
    Patil, Akshay Kalgonda
    Kurangi, Bhaskar Kallappa
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2022, 56 (03) : 865 - 872
  • [7] Dubey A, 2020, Review on Vinpocetine, V11, P6590
  • [8] RETRACTED: Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation (Retracted Article)
    Fahmy, Usama A.
    Badr-Eldin, Shaimaa M.
    Ahmed, Osama A. A.
    Aldawsari, Hibah M.
    Tima, Singkome
    Asfour, Hani Z.
    Al-Rabia, Mohammed W.
    Negm, Aya A.
    Sultan, Muhammad H.
    Madkhali, Osama A. A.
    Alhakamy, Nabil A.
    [J]. PHARMACEUTICS, 2020, 12 (06)
  • [9] ICH, 2005, VAL AN PROC TEXT MET, V1, DOI DOI 10.1590/S1984-82502011000100012
  • [10] VINPOCETINE: A SMART DRUG AND A SMART NUTRIENT: A REVIEW
    Jha, M. K.
    Rahman, M. H.
    Sheikh, Hasib
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (02): : 346 - 352